Trial intelligence / Profile preview

Pandel Cream 0.1% HPA Axis Study

NCT01137032Phase 4Completed

Sponsor
Fougera Pharmaceuticals Inc.
Start
Jun 2004
Primary completion
Aug 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of hydrocortisone probutate in psoriasis, atopic dermatitis (AD), sponsored by Fougera Pharmaceuticals Inc.. Started Jun 2004; status: completed.

02

Drugs

hydrocortisone probutate
03

Conditions

psoriasisatopic dermatitis (AD)

Beyond the preview

Go deeper on NCT01137032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01137032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call